Agomab Therapeutics NV (AGMB): SCHEDULE 13G filed May 6, 2026

Form type

SCHEDULE 13G

Filing date

May 6, 2026

Accession number

0001193125-26-207455

Filer

Agomab Therapeutics NV (CIK 2020932)